Fig Extract
CAS 90028-74-3
Fig Extract (CAS 90028-74-3) is a pharmaceutical compound with 0 bioactivity targets and 7 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Cross-Reference to Chemicals
Same-CAS substance identity is available in the industrial chemicals vertical.
FIG EXTRACT is linked to DTXSID101042862 in DSSTox identifiers.
View industrial chemical data →Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Fig Extract used for in pharmaceutical contexts?
Fig Extract (CAS 90028-74-3) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Fig Extract?
Fig Extract has 7 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Affect lability, Aggression, Drug ineffective, Fall, Mental impairment. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Fig Extract also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Fig Fruit Extract with EU status "restricted".
What clinical phase is Fig Extract in?
No phase 1-4 clinical development badge is rendered for Fig Extract because the matched compound identifier rows do not contain a max-phase value.